{"id":39699,"date":"2017-06-30T08:28:16","date_gmt":"2017-06-30T12:28:16","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=39699"},"modified":"2017-06-30T08:28:16","modified_gmt":"2017-06-30T12:28:16","slug":"trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699","title":{"rendered":"TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>TrovaGene Inc <\/strong><strong>(NASDAQ:TROV)<\/strong>, which happens to be a top end precision medicine biotechnology provider has proceeded to make the much awaited announcement. Through one of its top officials, it revealed that it was going to collaborate with a worldwide, premier biopharmaceutical company<strong>, <\/strong>an agreement that would see the two engage in the provision of Trovera\u00ae urine circulating tumor DNA (ctDNA) biomarker tests and services.<\/p>\n<p style=\"text-align: justify;\">According to <a href=\"https:\/\/finance.yahoo.com\/news\/trovagene-announces-agreement-global-biopharmaceutical-120000752.html\" target=\"_blank\" rel=\"noopener\">Yahoo<\/a>, Trovera\u00ae urine and blood liquid biopsy tests will be found quite useful by the researchers in carrying out various assessments as well as in doing a proper monitoring of the mutation status in clinical trials.<\/p>\n<p style=\"text-align: justify;\">The Chief Executive Officer of Trovagene, Bill Welch in a recent board meeting said, &#8220;We&#8217;re pleased to have our liquid biopsy tests included in the clinical trials with a leading biopharmaceutical company and to participate in their development of transformative therapies to improve the lives of cancer patients worldwide. This agreement follows a separate, recent announcement of our collaboration with AstraZeneca and demonstrates the value of our Trovera\u00ae biomarker technology.&#8221;<\/p>\n<p style=\"text-align: justify;\">Trovagene has over the years performed well in business despite the numerous challenges it has had to struggle with. A number of the top biopharmaceutical companies and clinical research third parties have a lot to thank the provider for. It has over the years performed a wide range of the CLIA laboratory testing services which have benefited the above mentioned bodies immensely.<\/p>\n<p style=\"text-align: justify;\">These are not the first two providers to come together under a common course. A lot of the top trusted providers do not rise to the top to become industry leaders on their own. They collaborate with each other to reach their set goals.<\/p>\n<p style=\"text-align: justify;\">Technological advancement has been given a lot of credit by some top researchers and experts. They have helped push towards the development of top solutions that have helped a lot of patients globally. The top provider is looking forward to generating higher revenues in future. It intends to use them to implement major business expansions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>TrovaGene Inc (NASDAQ:TROV), which happens to be a top end precision medicine biotechnology provider has proceeded to make the much awaited announcement. Through one of [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":39706,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[358,9901,12739,12740,9900],"stock_ticker":[],"class_list":["post-39699","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaq","tag-nasdaqtrov","tag-trov","tag-trovagene-inc","tag-trovagene-inc-nasdaqtrov","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"TrovaGene Inc (NASDAQ:TROV), which happens to be a top end precision medicine biotechnology provider has proceeded to make the much awaited announcement. Through one of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-30T12:28:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/06\/39705-images__7_.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"275\" \/>\n\t<meta property=\"og:image:height\" content=\"183\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fiona Gibson\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fiona Gibson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699\"},\"author\":{\"name\":\"Fiona Gibson\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e\"},\"headline\":\"TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials\",\"datePublished\":\"2017-06-30T12:28:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699\"},\"wordCount\":349,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/06\/39705-images__7_.jpeg\",\"keywords\":[\"NASDAQ\",\"NASDAQ:TROV\",\"TROV\",\"TrovaGene Inc\",\"TrovaGene Inc (NASDAQ:TROV)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699\",\"name\":\"TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/06\/39705-images__7_.jpeg\",\"datePublished\":\"2017-06-30T12:28:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/06\/39705-images__7_.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/06\/39705-images__7_.jpeg\",\"width\":275,\"height\":183},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e\",\"name\":\"Fiona Gibson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg\",\"caption\":\"Fiona Gibson\"},\"description\":\"Fiona is a finance graduate and an expert in analyzing market trends.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\",\"https:\/\/x.com\/@fionahime\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/fiona-gibson\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699","og_locale":"en_US","og_type":"article","og_title":"TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials - Wall Street PR","og_description":"TrovaGene Inc (NASDAQ:TROV), which happens to be a top end precision medicine biotechnology provider has proceeded to make the much awaited announcement. Through one of [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-06-30T12:28:16+00:00","og_image":[{"width":275,"height":183,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/06\/39705-images__7_.jpeg","type":"image\/jpeg"}],"author":"Fiona Gibson","twitter_misc":{"Written by":"Fiona Gibson","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699"},"author":{"name":"Fiona Gibson","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e"},"headline":"TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials","datePublished":"2017-06-30T12:28:16+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699"},"wordCount":349,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/06\/39705-images__7_.jpeg","keywords":["NASDAQ","NASDAQ:TROV","TROV","TrovaGene Inc","TrovaGene Inc (NASDAQ:TROV)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699","url":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699","name":"TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/06\/39705-images__7_.jpeg","datePublished":"2017-06-30T12:28:16+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/06\/39705-images__7_.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/06\/39705-images__7_.jpeg","width":275,"height":183},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trovagene-inc-nasdaqtrov-collaborates-with-global-biopharmaceutical-company-ahead-of-its-cancer-clinical-trials-39699#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e","name":"Fiona Gibson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg","caption":"Fiona Gibson"},"description":"Fiona is a finance graduate and an expert in analyzing market trends.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr","https:\/\/x.com\/@fionahime"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/fiona-gibson"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=39699"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39699\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/39706"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=39699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=39699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=39699"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=39699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}